Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing
17 Jan 2024 //
GLOBENEWSWIRE
Comanche secures $75M to test preeclampsia siRNA in PhII
17 Jan 2024 //
ENDPTS
Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888
23 Aug 2023 //
PR NEWSWIRE
Comanche Bio Strengthens Board of Directors with Appointment of Dr. Ann Taylor
13 Jun 2023 //
PR NEWSWIRE